Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via their national reporting system.
In the United Kingdom, healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme. Visit www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Adverse events should also be reported to Incyte immediately by phoning 0330‑100‑3677 (Great Britain) or 00‑800‑0002‑7423 (United Kingdom [Northern Ireland]).